INTERNATIONAL PATENT: TONIX PHARMA LIMITED FILES APPLICATION FOR "(S)-TIANEPTINE AND USE IN TREATING POST-CONCUSSIVE SYNDROME, NOCIPLASTIC PAIN SYNDROME AND CHRONIC OVERLAPPING PAIN CONDITIONS"

GENEVA, April 6 -- TONIX PHARMA LIMITED (3 Marine Road,Dun LaoghaireDublin, A96 HW25) filed a patent application (PCT/EP2025/077730) for "(S)-TIANEPTINE AND USE IN TREATING POST-CONCUSSIVE SYNDROME, NOCIPLASTIC PAIN SYNDROME AND CHRONIC OVERLAPPING PAIN CONDITIONS" on Sep 26, 2025. With publication no. WO/2026/068775, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEDERMAN, Seth (800 W. 38th St.,Apartment 2209Austin, Texas 78705), SULLIVAN, Gregory M. (230 Mapes RoadBarryville, New York 12719), HARRIS, Herbert W. (205 We...